In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Intensity Therapeutics Inc’s stock clocked out at $0.51, down -13.52% from its previous closing price of $0.59. In other words, the price has decreased by -$13.52 from its previous closing price. On the day, 0.7 million shares were traded.
Ratios:
To gain a deeper understanding of INTS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.30.
Stock Price History:
Over the past 52 weeks, INTS has reached a high of $5.10, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -54.63%, while the 200-Day Moving Average is calculated to be -79.37%.
Shares Statistics:
A total of 15.26M shares are outstanding, with a floating share count of 10.02M. Insiders hold about 45.56% of the company’s shares, while institutions hold 14.16% stake in the company.
Earnings Estimates
A detailed examination of Intensity Therapeutics Inc (INTS) is currently in progress, with 1 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.7 and -$0.7 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.45 and -$0.5.
